Iicoz et al. conducted a study to determine CSF and serum IL-6 levels in patients with NMO (23), optic neuritis (16), transverse myelitis (11), relapsing-remitting MS (27), and normal individuals (20). This evidence concerns the gene IL6 and neuromyelitis optica.